Angel One - Share Market Trading and Stock Broking
LoginOpen Demat Account
Skip to main content
Xilio Therapeutics, Inc. Common Stock logo

Xilio Therapeutics, Inc. Common Stock Share Price

NYSE: XLOHealthcare

$8.50

-0.82 (8.80%)
BUYSELL

Live Xilio Therapeutics, Inc. Common Stock Share Price Chart

O H L

Xilio Therapeutics, Inc. Common Stock Performance Overview

Days Range
▼
$9.32Low
$9.32High

Markets Today

Previous Close$9.00
Open$9.32
Volume6,197
Day's Range$9.32 - $9.32
52W Range$6.47 - $12.58
Market Cap$59.22 M

Historical Performance

1M Returns+1.01
3M Returns-3.02
6M Returns+3.57
1Y Returns-23.56
5Y ReturnsNA
10Y ReturnsNA

Xilio Therapeutics, Inc. Common Stock Fundamentals

Market Cap$59.22 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$43.77 M
ROE TTM-1.33
EPS TTM$-1.54
Quarterly Earnings Growth YOYN/A
PB Ratio0.82
EBITDA$-40.44 M
Profit Margin-80.05
Market Cap$59.22 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$43.77 M
ROE TTM-1.33
EPS TTM$-1.54
Quarterly Earnings Growth YOYN/A
PB Ratio0.82
EBITDA$-40.44 M
Profit Margin-80.05

Xilio Therapeutics, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$2.93 M$8.08 M$19.07 M$13.69 M$12.65 M$18.69 M
Gross Profit +$2.93 M$8.08 M$19.07 M$13.69 M$12.65 M$18.69 M
Operating Income -$13.85 M-$14.37 M-$1.93 M-$11.84 M-$14.11 M-$3.49 M
EBITDA -$13.35 M-$13.98 M-$1.59 M-$11.51 M-$13.77 M-$3.16 M
Interest Expense $0$0$0$0$0$0
Depreciation $497.00 K$381.00 K$340.00 K$323.00 K$344.00 K$331.00 K
Income Before Tax -$13.27 M-$15.84 M-$16.29 M$10.36 M-$9.53 M-$6.37 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$13.27 M-$15.84 M-$16.29 M$10.36 M-$9.53 M-$6.37 M
Net Profit Margin -452.73%-195.99%-85.42%75.7%-75.34%-34.09%

Xilio Therapeutics, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $5.00 K$5.00 K$5.00 K$0$1.00 K$1.00 K
Reserve & Surplus -$397.02 M-$412.86 M-$429.15 M-$418.79 M-$428.32 M-$434.69 M
Non-Current Liabilities $45.38 M$73.48 M$85.39 M$63.14 M$47.98 M$47.79 M
Current Liabilities $47.64 M$53.26 M$56.40 M$56.27 M$42.96 M$34.20 M
Total Liabilities $93.02 M$126.74 M$141.79 M$119.41 M$90.94 M$81.99 M
Fixed Assets $4.29 M$4.02 M$3.68 M$3.89 M$3.68 M$3.36 M
Current Assets $93.20 M$123.72 M$124.09 M$145.03 M$154.21 M$145.47 M
Total Assets $103.72 M$133.81 M$133.69 M$154.69 M$163.49 M$154.25 M

Xilio Therapeutics, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$13.27 M-$15.84 M-$16.29 M$10.36 M-$9.53 M-$6.37 M
Operating Cash Flow $28.98 M-$14.48 M-$17.50 M-$2.00 M-$22.34 M-$18.76 M
Investing Cash Flow -$22.00 K-$401.00 K$0-$95.00 K-$556.00 K-$19.00 K
Financing Cash Flow $4.83 M$47.36 M-$285.00 K$35.87 M$35.71 M$4.49 M
Change in Cash $33.79 M$32.48 M-$17.78 M$33.77 M$12.81 M-$14.29 M

Xilio Therapeutics, Inc. Common Stock Return Calculator

The Xilio Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
Invest in USA Stock Today

About Xilio Therapeutics, Inc. Common Stock

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

FAQs

Xilio Therapeutics, Inc. Common Stock (XLO) share price as of October 8, 2026 is $8.50. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Xilio Therapeutics, Inc. Common Stock (XLO) Share by opening an international trading account with Angel One.
Purchasing Xilio Therapeutics, Inc. Common Stock (XLO) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Xilio Therapeutics, Inc. Common Stock (XLO) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Xilio Therapeutics, Inc. Common Stock (XLO) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Xilio Therapeutics, Inc. Common Stock on October 8, 2026, is $59.22 M.
Xilio Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Xilio Therapeutics, Inc. Common Stock (XLO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Want to open an NRI account?
Top US Stocks

VIEW ALL